Intrahepatic Cholangiocarcinoma With Extrahepatic Metastasis and High Tumor Mutation Burden: Case of Complete Pathological Response to Cisplatin/Gemcitabine/Pembrolizumab

JCO Precis Oncol. 2024 Apr:8:e2300572. doi: 10.1200/PO.23.00572.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antibodies, Monoclonal, Humanized* / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols* / therapeutic use
  • Bile Duct Neoplasms* / drug therapy
  • Bile Duct Neoplasms* / genetics
  • Bile Duct Neoplasms* / pathology
  • Cholangiocarcinoma* / drug therapy
  • Cholangiocarcinoma* / genetics
  • Cholangiocarcinoma* / pathology
  • Cisplatin* / administration & dosage
  • Cisplatin* / therapeutic use
  • Deoxycytidine* / administration & dosage
  • Deoxycytidine* / analogs & derivatives
  • Deoxycytidine* / therapeutic use
  • Gemcitabine*
  • Humans
  • Male
  • Middle Aged
  • Mutation*
  • Neoplasm Metastasis

Substances

  • Gemcitabine
  • Deoxycytidine
  • Cisplatin
  • pembrolizumab
  • Antibodies, Monoclonal, Humanized